Bone Marrow Derived Mesenchymal Stem Cells Therapy(Next Generation Regenerative Medicine)

骨髓间充质干细胞疗法（Next Generation Regenerative Medicine）

Report date: 2023/01/12 15:41:10

Base Information

Drug NameBone Marrow Derived Mesenchymal Stem Cells Therapy(Next Generation Regenerative Medicine)
Drug Alias NameBone Marrow Derived MSCsBMDMSCs
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNext Generation Regenerative Medicine LLC
China Registration ClassN/A

Develop Information

Active CompaniesNext Generation Regenerative Medicine LLC
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A